Ovid Therapeutics
OVID
#9186
Rank
NZ$0.12 B
Marketcap
$1.77
Share price
-2.05%
Change (1 day)
-67.54%
Change (1 year)

Ovid Therapeutics (OVID) - Cash on Hand

Cash on Hand as of September 2024 : NZ$0.11 Billion

According to Ovid Therapeutics 's latest financial reports the company has NZ$0.11 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Ovid Therapeutics - Cash on Hand chart (from 2016 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.16 B-17.64%
2022-12-31NZ$0.20 B-26.1%
2021-12-31NZ$0.27 B175.4%
2020-12-31NZ$99.83 M-12.38%
2019-12-31NZ$0.11 B84.17%
2018-12-31NZ$61.87 M-49.57%
2017-12-31NZ$0.12 B63.61%
2016-12-31NZ$74.98 M-26.63%
2015-12-31NZ$0.10 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.48 B 334.32%๐Ÿ‡บ๐Ÿ‡ธ USA